The results showed significantly elevated expression levels of MYH9, MYL6, ACTN4, IQGAP1, and GYS1 in AD patients compared to HCs, while the expression of DSTN was significantly decreased (Figure 6). Here, IQGAP1 is linked to Alzheimer disease.